Zheng Quan Ri Bao Zhi Sheng·2025-08-27 11:12Core Insights - Shanghai MicroPort EP MedTech Co., Ltd. reported a revenue of 224 million yuan for the first half of 2025, representing a 12.80% increase from 198 million yuan in the same period last year [1] - The company's net profit attributable to shareholders reached 32.67 million yuan, a year-on-year increase of 92.02%, while the net profit after deducting non-recurring gains and losses was 20.81 million yuan, up 2157.44% [1] - The net cash flow from operating activities was 64.37 million yuan, reflecting a growth of 69.74% compared to the previous year [1] Revenue Growth - The revenue growth was primarily driven by the expansion of sales scale and continuous market penetration of products [1] - Overseas revenue saw a significant increase of over 40%, with products entering markets in Mexico, the UK, and Rwanda [1] Market Position - The company is one of the few globally that has completed a comprehensive layout of cardiac electrophysiology devices and consumables, and it is the first domestic manufacturer to provide a complete solution for three-dimensional cardiac electrophysiology devices and consumables [1] - The company aims to deepen market layout and provide integrated solutions for diagnosis and ablation treatment centered on precise interventional navigation, thereby consolidating its leading position in the field [1] Future Outlook - The company plans to continue focusing on technological innovation and breakthroughs, accelerate the commercialization of products, and further enhance market share while providing high-quality medical products and services to patients [1]